WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

DETERMINING SUITABLE SUBSTRATE CONVERSION FOR ENZYMATIC ASSAYS IN HIGH- THROUGHPUT SCREENING

Lakhan D. Baheti* and Rucha S. Tiwari

Abstract

It's generally accepted that the conversion of substrate should be kept at lower than 10% of the total substrate used when studying enzyme kinetics. still, 10 or lower substrate conversion frequently won't produce sufficient signal changes needed for robust HTS. To increase the signal- to- background rate, HTS is frequently performed at advanced than 10% substrate conversion. Because the consequences of high substrate conversion are inadequately understood, the webbing results are occasionally questioned by enzymologists. The quality of an assay is judged by the capability to describe an asset under HTS conditions, which depends on the robustness of the primary discovery signal (Z factor) and the perceptivity to an asset. The assay perceptivity to an asset is reflected in the observed IC50 value or percent inhibition at a fixed emulsion attention when single- point data are collected. The major concern for an enzymatic assay under high substrate conversion is that the perceptivity of the screen may be compromised. Here we decide the relationship between the IC50 value for a given asset and the chance of substrate conversion using a first- order kinetic model under conditions that observe Henri- Michaelis- Menten kinetics. The deduced theory was further vindicated experimentally with a cAMP-dependent protein kinase. This model provides guidance for assay inventors to choose an applicable substrate conversion in designing an enzymatic assay, balancing the requirements for robust signal and perceptivity to impediments. This composition reviews different possibilities for conducting enzymatic assays on microchip platforms, along with implicit advantages, limitations, and named exemplifications of similar biochips. Enzymegrounded chips combine the logical power and reagent frugality of microfluidic bias with the selectivity and modification features of biocatalytic responses. “Lab- on- chip” bias therefore allows enzymatic assays to be performed more fleetly, fluently, and economically. Similar assays generally calculate on- chip mixing and responses (of the substrates and enzymes) in connection to separations (of the substrates or products). The consummation of on- chip enzymatic assays therefore require understanding of how enzymatic responses bear on a small scale and can be connived with separation microchips, and how the microfluidics can be acclimated to suit the conditions of particular enzymatic assays. The thing is to gain sufficient response times, without compromising the quality of the logical separation. The versatility of similar on- chip enzymatic assays offer great promise for decentralised testing of clinically or environmentally important substrates.

Keywords: HTS, enzymatic assay, screening, Extracellular, Amylase, Lipase, Protease.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More